Go-to-market strategy and implementation for a new medical device for a respiratory indication
Defining the critical success factors and strategic/tactical requirements for the global market access strategy for a new medical technology
Context
The Challenge
- The company had developed a new medical technology for the treatment of highly prevalent respiratory indications
- The company required an assessment of the market landscape/segmentation across priority global markets to inform strategic planning and global/country specific tactical plans for execution of a successful launch (based on the requirements to optimise the pricing & reimbursement opportunity, and drive optimal positioning/patient access)
Requirements
Project Objectives
- Define the critical success factors for the global market access strategy/launch programme
- Define specific challenges/opportunities for the asset at the global and country level, and required mitigation
- Assess the evidence generation required for relevant value demonstration to drive access/uptake for the technology
- Define roadmaps for execution of global and country specific launch activities (for direct implementation by country specific local launch partners)
Methodology
Our Approach
- We undertook an extensive research programme with physicians, procurement and HTA/payer stakeholders detailing the market dynamics for the new device, and requirements to support the optimal clinical and commercial opportunity
- We developed a comprehensive go-to-market strategy based on the detailed analysis of the current/evolving market landscape, including the strategic/tactical requirements to achieve critical success factors at the global level and across individual markets
Outcomes
Value Delivered
- The client received a detailed assessment of the market opportunity for the asset, critical success factors for global/country specific launch and a strategic/tactical plan for implementation
- We provided a commercial forecast defining the optimal pricing potential across markets and the sensitivity of pricing/volume to potential tactics in the go-to-market strategy
- Global and country specific roadmaps were provided, detailing the actions (with a RACI matrix), timelines and resources/budget requirements for each activity within the launch programme (for direct implementation by country specific local launch partners)
